Multi-Center Phase Ii Study of Oral Azacitidine (Cc-486) Plus Chop as Initial Treatment for Peripheral T-Cell Lymphoma

Hematological Oncology - United Kingdom
doi 10.1002/hon.8_2632
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Randomized Phase Ii Study of Chop vs. Fractionated Iced in Transplant-Eligible Patients With Previously Untreated Peripheral T-Cell Lymphoma: Interim Results of Cisl1504

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Decitabine Plus R-Chop in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma: Interim Results of a Phase I/Ii Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Laboratory Correlates for a Phase II Trial of Romidepsin in Cutaneous and Peripheral T-Cell Lymphoma

British Journal of Haematology
Hematology
2010English

Chidamide in the Treatment of Peripheral T-Cell Lymphoma

OncoTargets and Therapy
OncologyPharmacology
2017English

A Phase II Study of Gemcitabine and Bexarotene (GemBex) in the Treatment of Cutaneous T-Cell Lymphoma

2012English

Recent Advances in the Treatment of Peripheral T‐Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2018English

Tellomak: T-Cell Lymphoma Anti-Kir3dl2 Therapy: An Open Label, Multi-Cohort, Multi-Center, International Phase Ii Study Evaluating the Efficacy and Safety of Iph4102 Alone or in Combination With Chemotherapy in Patients With Advanced T-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Hematopoietic SCT for Peripheral T-Cell Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2008English

Angioimmunoblastic T-Cell Lymphoma: A Rare Subtype of Peripheral T-Cell Lymphoma

Clinical Case Reports
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy